2022
DOI: 10.1038/s41579-022-00793-y
|View full text |Cite
|
Sign up to set email alerts
|

RNA-targeting CRISPR–Cas systems

Abstract: Important note To cite this publication, please use the final published version (if applicable).Please check the document version above.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(41 citation statements)
references
References 160 publications
0
29
0
Order By: Relevance
“…2 ) is that by invoking persistence (i.e., dormancy) through phage attack, back-up phage inhibition systems like restriction modification systems can degrade the phage genome since restriction enzymes do not require any resources from the cell for activity; i.e., Gibbs free energy is less than zero for phage DNA degradation due to the increase in entropy, so degradation of the phage genome can occur while the cells sleep. This general concept of allowing back-up DNA-targeting enzymes to function while the cell is dormant has been proposed for the type III/VI CRISPR-Cas systems 30, 44 and demonstrated while this work was being prepared for type VI CRISPR-Cas in Listeria spp. 47 ; however, the benefit of dormancy has not been suggested for the plethora of recently-discovered, non-CRSPR-Cas phage inhibition systems.…”
Section: Discussionmentioning
confidence: 99%
“…2 ) is that by invoking persistence (i.e., dormancy) through phage attack, back-up phage inhibition systems like restriction modification systems can degrade the phage genome since restriction enzymes do not require any resources from the cell for activity; i.e., Gibbs free energy is less than zero for phage DNA degradation due to the increase in entropy, so degradation of the phage genome can occur while the cells sleep. This general concept of allowing back-up DNA-targeting enzymes to function while the cell is dormant has been proposed for the type III/VI CRISPR-Cas systems 30, 44 and demonstrated while this work was being prepared for type VI CRISPR-Cas in Listeria spp. 47 ; however, the benefit of dormancy has not been suggested for the plethora of recently-discovered, non-CRSPR-Cas phage inhibition systems.…”
Section: Discussionmentioning
confidence: 99%
“…Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated endonuclease (Cas) system is a natural adaptive immune defense system; many bacteria and archaea use it against foreign genetic element invasions, such as bacteriophages (van Beljouw et al 2023 ). Since it was recognized as a genome editing tool in 2012 (Gasiunas et al 2012 ; Jinek et al 2012 ), CRISPR/Cas system and its applications have been attracting unprecedented attentions from both academic and industrial communities, including pharmaceutical and biomedical companies.…”
Section: Crispr/cas System Has Quickly Expanded In the Last One Decadementioning
confidence: 99%
“…These systems that recognize and target RNA include the type III-A and type III-B systems and other subtypes. Both have also been shown to stimulate non-specific, collateral RNA degradation and to have single-stranded DNase activity ( Makarova et al, 2011 ; Kolesnik et al, 2021 ; van Beljouw et al, 2022 ).…”
Section: Summary Of the Crispr-cas Systemmentioning
confidence: 99%